New World Development Company Limited   Report issue

For profit Phase 3
Founded: Hong Kong Hong Kong (1970)
Status: Left NME R&D (2012)

Organization Overview

First Clinical Trial
2002
NCT00119704
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2002

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 3 Trials (1)

rimabotulinumtoxinB (Myobloc) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Tennis Elbow (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 1